Shlomo Yanai

Insider Reports History

Location
One Meadowlands Plaza, East Rutherford, NJ
Signature
/s/ Darlene Quashie Henry, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shlomo Yanai:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Amneal Pharmaceuticals, Inc. Director Class A Common Stock 286K $2.4M $8.38 May 5, 2025 Direct
Philip Morris International Inc. Director Common Stock 8.76K $1.53M $174.82 May 7, 2025 Direct
Amneal Pharmaceuticals, Inc. Director Restricted Stock Units 34.8K $0 $5.31 May 6, 2025 Direct
W R GRACE & CO Director Common Stock, par value $0.01 per share 0 $70.00 Sep 22, 2021 Direct

Insider Reports Filed by Shlomo Yanai

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PM Philip Morris International Inc. May 7, 2025 1 $175K 4 May 9, 2025 Director
AMRX Amneal Pharmaceuticals, Inc. May 5, 2025 3 $0 4 May 8, 2025 Director
AMRX Amneal Pharmaceuticals, Inc. May 10, 2024 2 $0 4 May 14, 2024 Director
PM Philip Morris International Inc. May 8, 2024 1 $175K 4 May 10, 2024 Director
AMRX Amneal Pharmaceuticals, Inc. May 2, 2024 1 $0 4 May 6, 2024 Director
AMRX Amneal Pharmaceuticals, Inc. May 9, 2023 3 $0 4 May 11, 2023 Director
PM Philip Morris International Inc. May 3, 2023 1 $175K 4 May 5, 2023 Director
AMRX Amneal Pharmaceuticals, Inc. May 8, 2022 3 $0 4 May 10, 2022 Director
PM Philip Morris International Inc. May 4, 2022 1 $175K 4 May 6, 2022 Director
GRA W R GRACE & CO Sep 22, 2021 1 $0 4 Sep 22, 2021 Director
GRA W R GRACE & CO May 11, 2021 1 $0 4 May 12, 2021 Director
PM Philip Morris International Inc. May 5, 2021 1 $175K 4 May 7, 2021 Director
PM Philip Morris International Inc. May 5, 2021 0 $0 3 May 7, 2021 Director
AMRX Amneal Pharmaceuticals, Inc. May 5, 2021 3 $0 4 May 7, 2021 Director